Leuthner Brian A 4
4 · Edge Therapeutics, Inc. · Filed Aug 15, 2018
Insider Transaction Report
Form 4
Leuthner Brian A
Chief Executive Officer
Transactions
- Award
Restricted Stock Units
2018-08-14+169,032→ 169,032 total→ Common Stock (169,032 underlying)
Footnotes (3)
- [F1]Each restricted stock unit represents a contingent right to receive one share of Edge common stock upon the vesting of such unit.
- [F2]These restricted stock units shall become exercisable upon the achievement of certain performance or time based criteria.
- [F3]Expiration date is not applicable as the vested restricted stock units shall be settled on the first business day following the date that such restricted stock units vest.